India to Kenya: Dexamethasone Export Trade Route

The India to Kenya Dexamethasone corridor is one of India's established pharmaceutical export routes, with 387 shipments documented worth a combined $2.7M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's dexamethasone manufacturing sector.

Across 82 active suppliers, the average shipment value stands at $7.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with dexamethasone's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 21.7%, placing it at rank #14 among India's top dexamethasone export destinations globally.

On the import side, key buyers of Indian dexamethasone in Kenya include ABACUS PHARMA (AFRICA) LTD, ABACUS PHARMA (AFRICA) LTD , TO THE ORDER and 110 others. ABACUS PHARMA (AFRICA) LTD is the single largest importer with 47 shipments valued at $772.8K USD.

India's dexamethasone exports to Kenya are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 59 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 82 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, EAST AFRICAN INDIA OVERSEAS, ZYDUS LIFESCIENCES LIMITED — together account for 55% of total trade value on this route. The average shipment value of $7.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as dexona tablets 0.5mg (dexamethasone) 10x10 t and dexona e/e drop (neomycin sulphate anddexamethasone sodium phosphate ophthalmic solution usp) 5ml, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ABACUS PHARMA (AFRICA) LTD is the largest importer with 47 shipments worth $772.8K USD — representing 28% of all dexamethasone imports from India on this route. A total of 113 buyers are active on this corridor.